Meglumine
Meglumine is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.
Drug Details
- Generic Name
- Meglumine
- Brand Names
- N/A
- Application Number
- Sponsor
- Merck KGaA
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- MEGLUMINE
Indications and Usage
1 INDICATIONS AND USAGE Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated: for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. ( 1 )